Ultragenyx Pharmaceutical (RARE) Return on Capital Employed Growth (3y) (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Ultragenyx Pharmaceutical | 2.71 Bn | 2.30 Bn | 106.00 Mn | 195.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.00 |
| Dec 31, 2025 | -562.00 |
| Sep 30, 2025 | -1,113.00 |
| Jun 30, 2025 | -814.00 |
| Mar 31, 2025 | -1,401.00 |
| Dec 31, 2024 | -1,668.00 |
| Sep 30, 2024 | -1,387.00 |
| Jun 30, 2024 | -2,260.00 |
| Mar 31, 2024 | -2,994.00 |
| Dec 31, 2023 | -2,756.00 |
| Mar 31, 2023 | -834.00 |
| Dec 31, 2022 | -223.00 |
| Sep 30, 2022 | 189.00 |
| Jun 30, 2022 | 153.00 |
| Mar 31, 2022 | 1,493.00 |
| Dec 31, 2021 | 2,676.00 |
| Sep 30, 2021 | 2,502.00 |
| Jun 30, 2021 | 2,637.00 |
| Mar 31, 2021 | 3,923.00 |
| Dec 31, 2020 | 5,901.00 |